EFFICACY AND LONG TERM SAFETY STUDY OF DUPILUMAB IN ADULT PATIENTS WITH MODERATE0-TO-SEVERE ATOPIC DERMATITIS

Update Il y a 4 ans
Reference: EUCTR2013-003254-24

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Assess the efficacy of dupilumab over 12 weeks of treatment in adult patients with moderate-to-severe atopic dermatitis (AD) who have failed or are intolerant to topical steroids with or without topical calcineurin inhibitors.


Inclusion criteria

  • Moderate to severe atopic dermatitis (AD)